DLD Asset Management’s Entera Bio ENTX Stock Holding History

DLD Asset Management’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-369,000	Closed	-$919K	–	94
2019 Q3	$919K	Sell	369,000 -442	-0.1%	-$1.26K	0.05%	66
2019 Q2	$1.27M	Buy	369,442 +37,416	+11%	+$145K	0.05%	66
2019 Q1	$1.44M	Buy	332,026 +26,900	+9%	+$109K	0.05%	80
2018 Q4	$931K	Buy	305,126 +25,014	+9%	+$124K	0.06%	67
2018 Q3	$1.63M	Buy	280,112 +31,612	+13%	+$173K	0.08%	89
2018 Q2	$1.57M	Buy	+248,500	New	+$1.56M	0.12%	86

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DLD Asset Management's ENTX Position: Q4 2019 in Review

DLD Asset Management sold out of Entera Bio (ENTX) in Q4 2019, closing a stake of 369,000 shares — an estimated $919K sold.

DLD Asset Management first reported a position in ENTX in Q2 2018 and held it in 6 quarters. The position peaked at $1.63M in Q3 2018. 3 funds tracked by Wall St. Rank hold ENTX as of Q4 2019.

DLD Asset Management reported no remaining Entera Bio position as of Q4 2019 after selling out during the quarter.
DLD Asset Management sold 369,000 Entera Bio shares in Q4 2019, an estimated $919K.
DLD Asset Management first reported a position in Entera Bio in Q2 2018 and held it in 6 quarters.
DLD Asset Management's Entera Bio position peaked at $1.63M in Q3 2018.
3 funds tracked by Wall St. Rank held Entera Bio as of Q4 2019.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.